Oversold

GYRE

Same as last week
Valuation50/ 100
Cash flow & growth38/ 100
Upside potential45/ 100
Risk potential59/ 100

GYRE's valuation appears fair, below average fundamentals limit its appeal and weaker than expected earnings are holding it back, though analyst coverage is limited.

Valuation

Valuation stays neutral because earnings are difficult to compare across periods. Business trends, outlook and financial risk still contribute to the overall score.

Cash flow & growth

Business trends are weak. Over the past year: revenue +13.5%, operating margin -18.7 percentage points. Free cash flow is -14.1% of revenue. The business score is 37.7/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

Weaker business results limit upside support. Price history provides the reference because earnings are difficult to compare.

The calculation starts with the stock’s typical weekly price movements, adjusted for business performance and outlook. Unusually large jumps have less influence. The result is 48.6% upside, or about $10.19.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Historical price swings are the main risk driver, even without a sharp profit decline.

The stock’s historical price swings drive this figure; the separate operating stress is 52.1%. Price history and operating stress provide the reference because comparable earnings do not support a future PE target. Operating stress reflects revenue, earnings, margins, outlook and relevant debt exposure. The larger stress gives 58.6% downside, or about $2.84, with a 15% minimum.

This is a scenario based on our model, not a forecast or probability.

GYRE vs Historical averages

MetricCurrentAverageRelative
PE139x118x18% higher
PE percentile685035% higher
EPS-$0.20-$1.20$1.00 higher
FCF-$16.8M-$16.3M-$486.9K
Loading historical comparisons…

GYRE’s earnings are above their historical averages, while its earnings multiple is higher.

GYRE Forward outlook

MetricOutlook
Forward valuation--
Forward earningsLoss widening
Forward revenueGrowth
Forward profitabilityStrongly contracting
Analyst coverageLimited
Estimate dispersionTight

GYRE’s outlook is mixed, with weaker expected earnings weighing on the picture.

GYRE PE Valuation

Loading pe valuation table…

This table applies GYRE's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

GYRE Earnings Per Share

Loading earnings per share…

This chart tracks GYRE's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

GYRE Quarterly Revenue

Loading quarterly revenue…

This chart tracks GYRE's quarterly revenue over time and shows how sales are changing from year to year.

GYRE Free Cash Flow

Loading free cash flow…

This chart tracks GYRE's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

GYRE Total Shares

Loading shares over time…

This chart tracks changes in GYRE's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

GYRE Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

GYRE PE vs Healthcare Sector

Loading pe vs sector average…

This chart compares GYRE's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

GYRE Weekly Price

Loading weekly price…

This chart uses GYRE's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

GYRE Weekly Moving Averages

Loading weekly moving averages…

This chart compares GYRE's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

GYRE Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.